Compounds > telmisartan
Page last updated: 2024-08-24

telmisartan and angiotensin ii

telmisartan has been researched along with angiotensin ii in 127 studies

Research

Studies (127)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (7.87)18.2507
2000's65 (51.18)29.6817
2010's42 (33.07)24.3611
2020's10 (7.87)2.80

Authors

AuthorsStudies
Entzeroth, M; Hauel, N; Narr, B; Ries, U; Van Meel, JC; Wienen, W1
Entzeroth, M; Hasselbach, KM; Hauel, NH; Mihm, G; Narr, B; Ries, UJ; van Meel, JC; Wienen, W; Wittneben, H1
Haigh, RM; Redemann, N; van Meel, JC1
Heinemann, A; Holzer, P; Peskar, BA; Wachter, CH1
Heinemann, A; Holzer, P; Jocic, M; Sattler, V; Wienen, W1
Kirk, JK1
Kaplan, NM1
Arnold, JM; Azevedo, ER; Baird, MG; Butt, RW; Humen, DP; Moe, GW; Parker, AB; Parker, JD; Parker, JO; Smith, SJ1
Hoshi, K; Ichihara, K; Kosugi, T; Nakai, T; Satoh, K1
Heinemann, A; Horina, G; Pieber, D; Pieber, TR; Sandner-Kiesling, A1
Casado, S; Farré, J; Gómez, J; Jiménez, A; López-Blaya, A; López-Farré, A; Montón, M; Núñez, A; Sánchez de Miguel, L; Zalba, LR1
Howes, L; Wong, W1
Vidt, DG1
Balt, JC; Mathy, MJ; Pfaffendorf, M; van Zwieten, PA1
Ramahi, TM1
Meredith, PA; Weber, MA1
Fagard, RH; Lijnen, PJ; Petrov, VV2
Culman, J; Gohlke, P; Jansen, A; Rascher, W; Stangier, J; Unger, T; Weiss, S; Wienen, W1
Balt, JC; Mathy, MJ; Nap, A; Pfaffendorf, M; van Zwieten, PA1
Fagard, RH; Jackson, KC; Lijnen, PJ; Petrov, VV1
Goa, KL; Jarvis, B; Sharpe, M1
de Bruin, H; Jonkman, JH; Meinicke, T; Stangier, J; Su, CA; Tamminga, WJ; van Heiningen, PN; van Lier, JJ1
Biggi, A; Carra, N; Fasoli, E; Iori, V; Montanari, A; Novarini, A; Perinotto, P1
Brunner, HR; Burnier, M; Centeno, C; Maillard, MP; Perregaux, C; Stangier, J; Wienen, W1
Balt, JC; Nap, A; Pfaffendorf, M; Van Zwieten, PA1
Engeli, S; Gorzelniak, K; Janke, J; Luft, FC; Sharma, AM1
Buranakitjaroen, P; Phoojaroenchanachai, M; Sangprasert, P; Saravich, S1
Chernova, NA; Fomicheva, OA; Ivanova, OV; Karpov, YA; Rogoza, AN; Sergakova, LM1
Hankey, GJ1
Unger, T1
Amano, S; Inagaki, Y; Okamoto, T; Yamagishi, S1
Dominiak, P; Häuser, W1
Gilles, R; Griffin, M; Howes, JB; Howes, LG; Vingerhoedt, NM1
Matos, L1
Bohner, H; Heemann, U; Köster, J; Michel, MC; Schäfers, R1
Baffoni, L; Durante, V; Grossi, M1
Drexler, H; Fuchs, M; Grote, K; Hilfiker, A; Hilfiker-Kleiner, D; Kaminska, A; Kaminski, K; Kiian, I; Klein, G; Podewski, E; Wollert, KC1
Unger, T; Zimmermann, M1
Clasen, R; Clemenz, M; Foryst-Ludwig, A; Kintscher, U; Krikov, M; Schupp, M; Sprang, C; Thöne-Reineke, C; Unger, T1
Imaizumi, T; Inoue, H; Matsui, T; Nakamura, K; Takeuchi, M; Yamagishi, S1
Atkinson, J; Chan, SL; Chillon, JM; Kwan, YW; Perrin-Sarrado, C; Vincent, JM1
Imaizumi, T; Jinnouchi, Y; Matsui, T; Nakamura, K; Nakamura, Y; Takenaka, K; Yamagishi, S1
Feng, YQ; Nie, J; Wei, F; Zhang, M; Zhang, YF1
Jin, D; Kirimura, K; Mino, Y; Miyazaki, M; Muramatsu, M; Takai, S; Yoshikawa, K1
Boku, N; Eto, M; Kajihara, N; Morita, S; Nishida, T; Tatewaki, H1
Devereux, RB; Krauser, DG1
Inoue, M; Ishida, S; Izumi-Nagai, K; Kubota, Y; Nagai, N; Noda, K; Oike, Y; Ozawa, Y; Suda, T; Tsubota, K; Urano, T1
Fukuyama, K; Hashiguchi, Y; Ichiki, T; Imayama, I; Inanaga, K; Ohtsubo, H; Ono, H; Sunagawa, K1
Cibulskyte, D; Frøkiaer, J; Hansen, HE; Hørlyck, A; Madsen, M; Marcussen, N; Mortensen, J; Pedersen, M1
Black, S; Cassis, LA; Gibson, LL; Hahner, L; Osborne-Lawrence, S; Samols, D; Schwartz, R; Shaul, PW; Thomas, GD; Vongpatanasin, W1
Ishiguro, H; Ishiguro, Y; Kubota, Y; Uemura, H1
Miura, S; Saku, K1
Le, MT; Pugsley, MK; Van Liefde, I; Vauquelin, G1
Petkow-Dimitrow, P1
Chen, XY; Du, GT; Ji, H; Li, YQ; Meng, ZK; Shi, WB; Tian, J; Zhang, YH1
Isobe, A; Kimura, T; Minekawa, R; Miyake, A; Nishimoto, F; Oskamoto, Y; Sakata, M; Takeda, T; Walker, CL; Yamamoto, T1
Duan, SB; Jiang, WL; Li, J; Li, YJ; Liu, FY; Liu, YH; Peng, YM; Wang, YH; Xu, XQ; Zou, Q1
Bode-Böger, SM; Bukowska, A; Lendeckel, U; Martens-Lobenhoffer, J; Scalera, F; Täger, M1
Jin, D; Kimura, M; Kirimura, K; Miyazaki, M; Sakonjo, H; Takai, S; Tanaka, K1
Leenen, FH; Liang, B1
Cai, YM; Gu, HB; Hao, YH; He, JG; Hu, XS; Liao, XX; Ma, H; Tian, F; Wang, LJ; Zhang, WW; Zhou, QL; Zou, HM1
Imamura, Y; Ishida, S; Kurihara, T; Nagai, N; Noda, K; Oike, Y; Okano, H; Ozawa, Y; Shinoda, K; Tsubota, K1
Hosomi, N; Imanishi, M; Ito, S; Kiyomoto, H; Kobori, H; Konishi, Y; Meda, I; Mori, T; Morikawa, T; Nagai, Y; Nakagawa, T; Nishiyama, A; Okada, N; Okumura, M1
Amano, S; Iriyama, A; Ishida, S; Nagai, N; Sugisaki, K; Usui, T; Yamagami, S; Yokoo, S1
Haider, DG; Jungbauer, A; Kapiotis, S; Mueller, M; Storka, A; Vojtassakova, E; Wolzt, M1
Cao, T; Chen, X; Feng, X; He, H; Liu, D; Luo, Z; Ma, L; Tepel, M; Wang, L; Yan, Z; Yang, D; Zhu, Z1
Schindler, C1
Banks, WA; Doghu, S; Fleegal-DeMotta, MA1
Akiyoshi, Y; Miyamoto, S; Morishima, M; Ono, K; Wang, Y1
Auffarth, GU; Bettendorf, M; Grundt, C; Inta, I; Lemmer, B; Schwaninger, M; Veltkamp, R; Weber, D; Winteroll, S1
Kagota, S; Kunitomo, M; Nakamura, K; Nejime, N; Shinozuka, K; Tada, Y1
Cheng, YX; Pan, Q; Yang, XH1
Duan, SB; Liu, FY; Peng, YM; Wang, P; Wang, YH; Xu, XQ; Zou, Q1
Brillante, DG; Brillante, RE; Howes, LG; O'Sullivan, AJ1
Chander, PN; Charney, DN; Ding, G; Kumar, D; Singhal, PC; Vallabu, S; Yadav, A1
Hara, Y; Okada, M; Yamawaki, H1
Alonso, D; Botello-Amaro, CA; Jimenez-Ferrer, E; Perez, YY; Zamilpa, A1
Arsenault, J; Cabana, J; Escher, E; Guillemette, G; Lanthier, L; Lavigne, P; Leduc, R; Lehoux, J1
Aoki, A; Ichikawa, S; Kumakura, H; Nitta, K; Ogawa, T; Sumino, H; Takayama, Y1
Di Lorenzo, A; Kauser, K; Krieger, MH; Sessa, WC; Teutsch, C1
Lorincz, A; Lutz, S; Thomas, MA; Vettel, C; Wieland, T; Wuertz, CM1
Banno, F; Inoue, N; Kamide, K; Kawano, Y; Matsumoto, S; Miyata, T; Mochizuki, N1
Aizawa, Y; Arozal, W; Kodama, M; Ma, M; Sukumaran, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K1
Fujimura, T; Fushida, S; Hayashi, H; Kayahara, M; Kitagawa, H; Nakagawara, H; Nakanuma, S; Ohnishi, I; Ohta, T; Okamoto, K; Tajima, H; Takamura, H; Tani, T1
Aizawa, Y; Giridharan, VV; Harima, M; Kodama, M; Lakshmanan, AP; Sari, FR; Soetikno, V; Thandavarayan, RA; Watanabe, K1
Arfa, O; Czech, T; Ebrahimian, T; Endtmann, C; Fritz, M; Laufs, U; Nickenig, G; Petoumenos, V; Wassmann, K; Wassmann, S; Werner, N1
Li, H; Liu, Q; Wang, N; Xu, J1
Jöhren, O; Miesel, A; Müller-Fielitz, H; Raasch, W; Vogt, FM1
Chen, HY; Chen, LF; Fang, Q; Wang, W; Xu, Z; Yan, XW1
Ihm, CG; Jeong, KH; Lee, GJ; Lee, SH; Lee, TW; Moon, JY; Park, HK1
Al-Mulhim, AS; Fouad, AA; Gomaa, W; Jresat, I1
Asanuma, K; Fukami, K; Kaida, Y; Kaifu, K; Matsui, T; Okuda, S; Takeuchi, M; Ueda, S; Yamagishi, S1
Chen, BX; Du, FH; Gong, HT; Guo, CX; Li, Q; Ma, XL; Xu, XY1
Cantalupo, A; Di Lorenzo, A; Giordano, FJ; Huang, Y; Jiang, W; Sessa, WC1
Guan, G; Ma, A; Shao, L; Tian, G; Wang, J; Wang, Y; Zhang, Y1
Abe, T; Aukema, HM; Horie, S; Kugita, M; Nagao, S; Nakanishi, K; Sasaki, M; Yamaguchi, T; Yoshihara, D1
Liu, SS; Tang, JM; Wang, HY; Zhou, XM1
Braszko, JJ; Wincewicz, D1
Eriguchi, M; Fujisaki, K; Haruyama, N; Kitazono, T; Noguchi, H; Torisu, K; Tsuruya, K; Yamato, M1
Agrawal, DK; Ikhapoh, IA; Pelham, CJ1
Bader, M; Barkhausen, J; Raasch, W; Santos, RA; Schuchard, J; Schuster, F; Stölting, I; Thorns, C; Vogt, FM; Winkler, M1
Bali, A; Jaggi, AS1
Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V; Pandey, A1
Hou, L; Hu, H; Lin, Z; Ni, Y; Song, L; Wu, Y; Yang, D; Zhang, J1
Cui, QW; Guan, GC; Liu, B; Tian, G; Wang, JK; Zhang, Y; Zhao, NA; Zhu, HL; Zhu, SM1
Chen, PP; Hu, ZB; Liu, BC; Liu, L; Lu, J; Ma, KL; Ruan, XZ; Wang, GH; Wen, Y; Wu, Y; Zhang, Y1
Jöhren, O; Mildner, M; Müller-Fielitz, H; Raasch, W; Steckelings, M; Stölting, I1
Bi, G; Cao, K; Fang, D; He, Y; Li, Z; Song, X; Wang, F; Wei, Y; Wu, J; Yang, J; Zhang, Z1
Jin, Z; Sun, B; Tan, Q1
Dalman, RL; Iida, Y; Miyata, M; Xu, B; Xuan, H1
Cao, ZJ; Feng, YJ; Huo, HY; Jiao, XY; Li, D; Wang, J; Zhang, XM1
Chae, SJ; Ihm, CG; Jeong, KH; Kang, SW; Kim, JH; Kim, JS; Kim, YG; Lee, GJ; Lee, SH; Lee, TW; Lee, YH; Moon, JY; Park, HK1
Chen, X; Lin, Y; Luo, W; Shi, Y; Song, A; Wang, W; Zeng, Y; Zhang, Y1
Cai, JH; Cheng, X; Ewurum, HC; Luo, X; Wang, M; Yang, YY; Zeng, HQ; Zeng, YM; Zhang, XB1
Li, J; Li, YP; Shen, ZJ; Xia, P; Xu, CS; Xu, JJ1
Higashi, Y; Nagao, Y; Saito, M; Shimizu, S; Shimizu, T1
Finger, S; Garlapati, V; Karbach, SH; Knopp, T; Knorr, M; Kossmann, S; Lagrange, J; Molitor, M; Münzel, T; Nguyen, TS; Rudi, WS; Ruf, W; Schüler, R; Wenzel, P; Wild, J1
Abdelghany, RH; Badr, S; Rezq, S1
Bilen, A; Celik, M; Celik, Z; Gulaboglu, M; Halici, Z; Kul, A; Kutlu, Z; Maman, A1
Bai, L; Chen, Y; Gao, J; Guo, X; Lai, B; Shang, F; Wang, C; Wen, E1
Kawada, T; Li, M; Saku, K; Sawada, S; Suehara, S; Sugimachi, M; Uemura, K; Zheng, C1
Bernatchez, P; Esfandiarei, M; Milad, N; Rossi, FMV; Sauge, E; Seidman, MA; Tehrani, AY; Theret, M; Tung, LW; van Breemen, C; White, Z; Zhao, RRY1
Agbaraolorunpo, F; Anigbogu, CN; Ogunnowo, SA; Oloyo, AK; Sofola, O1
Asgharzadeh, F; Askarnia-Faal, MM; Avan, A; Daghiani, M; Hassanian, SM; Khazaei, M; Naimi, H; Nazari, SE; Sayyed-Hosseinian, SH; Vahedi, E1
Lan, T; Li, XC; Li, ZQ; Quan, W; Tang, F; Wang, MY; Wang, ZF; Xu, CS; Yang, C; Yu, DH1
Lu, TL; Wu, SN1

Reviews

12 review(s) available for telmisartan and angiotensin ii

ArticleYear
Angiotensin-II receptor antagonists: their place in therapy.
    American family physician, 1999, Volume: 59, Issue:11

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Heart Failure; Humans; Hypertension; Irbesartan; Losartan; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan

1999
Angiotensin II receptor antagonists in the treatment of hypertension.
    American family physician, 1999, Sep-15, Volume: 60, Issue:4

    Topics: Algorithms; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Hypertension; Irbesartan; Losartan; Receptors, Angiotensin; Telmisartan; Tetrazoles; Valine; Valsartan

1999
Angiotensin receptor antagonists.
    Australian family physician, 2000, Volume: 29, Issue:7

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Hypertension; Irbesartan; Losartan; Telmisartan; Tetrazoles

2000
Expanded role for ARBs in cardiovascular and renal disease? Recent observations have far-reaching implications.
    Postgraduate medicine, 2001, Volume: 109, Issue:4

    Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biological Availability; Biphenyl Compounds; Cardiovascular Diseases; Humans; Imidazoles; Irbesartan; Kidney Diseases; Losartan; Metabolic Clearance Rate; Patient Selection; Renin-Angiotensin System; Telmisartan; Tetrazoles; Thiophenes; Treatment Outcome; Valine; Valsartan

2001
Telmisartan: a review of its use in hypertension.
    Drugs, 2001, Volume: 61, Issue:10

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Drug Interactions; Heart Failure; Humans; Hypertension; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome

2001
Angiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE?
    Stroke, 2003, Volume: 34, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Life Style; Practice Guidelines as Topic; Ramipril; Risk; Risk Factors; Stroke; Telmisartan

2003
The ongoing telmisartan alone and in combination with ramipril global endpoint trial program.
    The American journal of cardiology, 2003, May-22, Volume: 91, Issue:10A

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Ramipril; Renin-Angiotensin System; Telmisartan

2003
[New possibilities in clinical use of angiotensin II receptor inhibitors].
    Orvosi hetilap, 2003, Dec-07, Volume: 144, Issue:49

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Ramipril; Renin-Angiotensin System; Survival Analysis; Telmisartan; Treatment Outcome

2003
Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
    Herz, 2006, Volume: 31, Issue:4

    Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan

2006
[New therapeutic targets for ACE inhibitors and angiotensin receptor blockers].
    Polskie Archiwum Medycyny Wewnetrznej, 2007, Volume: 117, Issue:4

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Losartan; Metabolic Syndrome; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Risk Reduction Behavior; Telmisartan; Treatment Outcome

2007
Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms.
    Current drug targets, 2018, Volume: 19, Issue:11

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Aneurysm, Abdominal; Aortic Rupture; Clinical Trials as Topic; Disease Models, Animal; Disease Progression; Humans; Receptor, Angiotensin, Type 1; Telmisartan; Valsartan

2018
Investigating the Impact of Selective Modulators on the Renin-Angiotensin-Aldosterone System: Unraveling Their Off-Target Perturbations of Transmembrane Ionic Currents.
    International journal of molecular sciences, 2023, Sep-12, Volume: 24, Issue:18

    Topics: Angiotensin II; Blood Pressure; Glucocorticoids; Humans; Receptor, Endothelin A; Renin-Angiotensin System; Telmisartan

2023

Trials

9 trial(s) available for telmisartan and angiotensin ii

ArticleYear
ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada.
    American heart journal, 1999, Volume: 138, Issue:5 Pt 1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Benzimidazoles; Benzoates; Canada; Catheterization, Peripheral; Coronary Care Units; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Renin; Safety; Telmisartan; Treatment Outcome

1999
Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge.
    Journal of cardiovascular pharmacology, 2001, Volume: 38, Issue:5

    Topics: Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Headache; Humans; Hypertension; Male; Plethysmography; Pulse; Telmisartan

2001
[Angiotensin II receptor blocker telmisartan: effect on 24-hour blood pressure profile and left ventricular hypertrophy in patients with hypertension].
    Kardiologiia, 2002, Volume: 42, Issue:2

    Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Circadian Rhythm; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Receptors, Angiotensin; Telmisartan

2002
Haemodynamic and pulse wave responses to intravenous infusions of angiotensin II during chronic telmisartan therapy in normal volunteers.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2003, Volume: 4, Issue:4

    Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiac Output; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Pulse; Reference Values; Telmisartan; Vascular Resistance

2003
Safety of telmisartan in patients with arterial hypertension : an open-label observational study.
    Drug safety, 2004, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Risk Factors; Telmisartan

2004
Challenges in improving prognosis and therapy: the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial programme.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Germany; Heart Diseases; Humans; Hypertension; Prognosis; Ramipril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Reduction Behavior; Telmisartan; Treatment Outcome

2004
Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome.
    Blood pressure, 2009, Volume: 18, Issue:3

    Topics: Adult; Angiotensin II; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular System; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Hemodynamics; Humans; Insulin Resistance; Male; Metabolic Syndrome; Nitric Oxide Synthase; omega-N-Methylarginine; Photoplethysmography; Receptor, Angiotensin, Type 1; Telmisartan; Vascular Resistance

2009
Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration.
    Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:3

    Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Apoptosis; Benzimidazoles; Benzoates; Blood Vessels; Bone Marrow Transplantation; Cell Count; Cells, Cultured; Coronary Artery Disease; Double-Blind Method; Endothelial Cells; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Ramipril; Receptor, Angiotensin, Type 1; Regeneration; Stem Cells; Telmisartan; Vasoconstrictor Agents

2011
Polymorphisms of the angiotensin II type 1 receptor gene affect antihypertensive response to angiotensin receptor blockers in hypertensive Chinese.
    Genetics and molecular research : GMR, 2013, Jun-21, Volume: 12, Issue:2

    Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Asian People; Benzimidazoles; Benzoates; Blood Pressure; Drug Administration Schedule; Essential Hypertension; Female; Genotype; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Single-Blind Method; Telmisartan; Young Adult

2013

Other Studies

106 other study(ies) available for telmisartan and angiotensin ii

ArticleYear
Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
    British journal of pharmacology, 1993, Volume: 110, Issue:1

    Topics: Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Blood Pressure; Decerebrate State; Dose-Response Relationship, Drug; Female; Humans; Hypertension, Renovascular; In Vitro Techniques; Lung; Male; Muscle Contraction; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Renin; Telmisartan

1993
6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.
    Journal of medicinal chemistry, 1993, Dec-10, Volume: 36, Issue:25

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Binding Sites; Blood Pressure; Male; Models, Molecular; Rats; Rats, Wistar; Receptors, Angiotensin; Structure-Activity Relationship; Telmisartan

1993
Hypotensive effects of the angiotensin II antagonist telmisartan in conscious chronically-instrumented transgenic rats.
    Arzneimittel-Forschung, 1996, Volume: 46, Issue:8

    Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Captopril; Heart Rate; Imidazoles; Losartan; Rats; Telmisartan; Tetrazoles

1996
Dilatation by angiotensin II of the rat femoral arterial bed in vivo via pressure/flow-induced release of nitric oxide and prostaglandins.
    British journal of pharmacology, 1997, Volume: 122, Issue:6

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Bosentan; Female; Femoral Artery; Hexamethonium; Indomethacin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prazosin; Propranolol; Prostaglandins; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sulfonamides; Telmisartan; Vasodilation

1997
Effect of angiotensin II and telmisartan, an angiotensin1 receptor antagonist, on rat gastric mucosal blood flow.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Diffusion; Female; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Heart Rate; Hypotension; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Telmisartan; Vasoconstrictor Agents

1999
Participation of angiotensin II and bradykinin in contractile function in dog stunned myocardium.
    European journal of pharmacology, 1999, Oct-15, Volume: 382, Issue:3

    Topics: Adenosine Triphosphate; Anesthesia; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Enalapril; Female; Heart Rate; In Vitro Techniques; Ligation; Male; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Telmisartan; Time Factors; Ventricular Pressure

1999
Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats.
    Cardiovascular research, 1999, Volume: 44, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Benzimidazoles; Benzoates; Blood Pressure; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Glyburide; Hemodynamics; Indomethacin; Male; Mesenteric Artery, Superior; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Shock, Hemorrhagic; Telmisartan; Time Factors; Vasoconstrictor Agents

1999
Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antibodies, Monoclonal; Benzimidazoles; Benzoates; Binding, Competitive; Biphenyl Compounds; Blood Platelets; Dose-Response Relationship, Drug; Humans; Imidazoles; Irbesartan; Losartan; Platelet Activation; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Telmisartan; Tetrazoles; Thromboxane A2; Time Factors; Valine; Valsartan

2000
Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?
    Cleveland Clinic journal of medicine, 2001, Volume: 68, Issue:3

    Topics: Acrylates; Angioedema; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Black or African American; Clinical Trials as Topic; Cough; Female; Humans; Imidazoles; Irbesartan; Losartan; Male; Randomized Controlled Trials as Topic; Sex Factors; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan

2001
Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
    Journal of hypertension, 2001, Volume: 19, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Captopril; Decerebrate State; Electric Stimulation; Irbesartan; Losartan; Male; Norepinephrine; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sympathetic Nervous System; Synaptic Transmission; Telmisartan; Tetrazoles

2001
Angiotensin II receptor antagonists: new paradigms in the treatment of hypertension. Introduction.
    Blood pressure. Supplement, 2001, Volume: 1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Humans; Hypertension; Telmisartan

2001
Induction of cardiac fibrosis by angiotensin II.
    Methods and findings in experimental and clinical pharmacology, 2000, Volume: 22, Issue:10

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Collagen; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Fibroblasts; Fibrosis; Lisinopril; Male; Myocardium; Rats; Rats, Wistar; Telmisartan; Time Factors; Transforming Growth Factor beta

2000
AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Benzimidazoles; Benzoates; Blood Pressure; Blood-Brain Barrier; Drinking; Male; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Telmisartan; Vasoconstrictor Agents

2001
Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
    Journal of cardiovascular pharmacology, 2001, Volume: 38, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Dose-Response Relationship, Drug; Electric Stimulation; Irbesartan; Losartan; Male; Mesenteric Arteries; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sympathetic Nervous System; Telmisartan; Tetrazoles; Vasoconstrictor Agents

2001
Effect of telmisartan on angiotensin II-mediated collagen gel contraction by adult rat cardiac fibroblasts.
    Journal of cardiovascular pharmacology, 2001, Volume: 38, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Collagen Type I; Fibroblasts; Male; Myocardial Contraction; Myocardium; Rats; Rats, Wistar; Telmisartan; Vasoconstrictor Agents

2001
Angiotensin II-induced stimulation of collagen secretion and production in cardiac fibroblasts is mediated via angiotensin II subtype 1 receptors.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2001, Volume: 2, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Collagen; Fibroblasts; Fluorescent Antibody Technique; Imidazoles; Male; Myocardium; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Telmisartan; Vasoconstrictor Agents

2001
Renal hemodynamic control by endothelin and nitric oxide under angiotensin II blockade in man.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:2 Pt 2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Endothelins; Hemodynamics; Humans; Kidney; Nitric Oxide; Telmisartan

2002
In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Cell Membrane; In Vitro Techniques; Irbesartan; Kinetics; Muscle, Smooth, Vascular; Radioligand Assay; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Telmisartan; Tetrazoles

2002
Sympatholytic properties of several AT1-receptor antagonists in the isolated rabbit thoracic aorta.
    Journal of hypertension, 2002, Volume: 20, Issue:9

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Benzimidazoles; Benzoates; Biphenyl Compounds; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Irbesartan; Losartan; Norepinephrine; Osmolar Concentration; Rabbits; Receptor, Angiotensin, Type 1; Sympathetic Nervous System; Sympatholytics; Synaptic Transmission; Telmisartan; Tetrazoles

2002
Angiotensin blockade prevents type 2 diabetes by formation of fat cells.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:5

    Topics: Adipocytes; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cell Differentiation; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Telmisartan

2002
The efficacy and tolerability of an angiotensin II receptor blocker, telmisartan, in Thai patients with mild to moderate essential hypertension.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2002, Volume: 85, Issue:9

    Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Male; Middle Aged; Single-Blind Method; Telmisartan; Thailand

2002
Angiotensin II stimulates platelet-derived growth factor-B gene expression in cultured retinal pericytes through intracellular reactive oxygen species generation.
    International journal of tissue reactions, 2003, Volume: 25, Issue:2

    Topics: Acetylcysteine; Amino Acid Sequence; Angiotensin II; Animals; Base Sequence; Benzimidazoles; Benzoates; Cattle; Cells, Cultured; Cloning, Molecular; Gene Expression Regulation; Humans; Molecular Sequence Data; Pericytes; Proto-Oncogene Proteins c-sis; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Sheep; Telmisartan; Transcriptional Activation

2003
[Dosage equivalents of AT1-receptor antagonists available in Germany].
    Deutsche medizinische Wochenschrift (1946), 2003, Oct-31, Volume: 128, Issue:44

    Topics: Acrylates; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Germany; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Olmesartan Medoxomil; Placebos; Telmisartan; Tetrazoles; Therapeutic Equivalency; Thiophenes; Time Factors; Valine; Valsartan

2003
Acute pancreatitis induced by telmisartan overdose.
    The Annals of pharmacotherapy, 2004, Volume: 38, Issue:6

    Topics: Acute Disease; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Drug Overdose; Humans; Male; Pancreatitis; Telmisartan

2004
Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation.
    Circulation, 2004, May-11, Volume: 109, Issue:18

    Topics: Alkaloids; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Benzophenanthridines; Cell Movement; Cells, Cultured; Cysteine-Rich Protein 61; Flavonoids; Gene Expression Regulation; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Interleukin-6; Leukemia Inhibitory Factor; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Myocytes, Smooth Muscle; Naphthalenes; Neovascularization, Physiologic; Norepinephrine; Paracrine Communication; Phenanthridines; Phenylephrine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; RNA, Messenger; Stress, Mechanical; Telmisartan; Tumor Necrosis Factor-alpha

2004
PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
    Hypertension (Dallas, Tex. : 1979), 2005, Volume: 46, Issue:1

    Topics: 3T3-L1 Cells; Adipocytes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Cycloheximide; Insulin Resistance; Irbesartan; Mice; Obesity; PPAR gamma; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Rats; Rats, Zucker; Receptor, Angiotensin, Type 2; Telmisartan; Tetrazoles

2005
Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression.
    FEBS letters, 2005, Aug-15, Volume: 579, Issue:20

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Cells, Cultured; Diabetic Retinopathy; Glycation End Products, Advanced; NF-kappa B; Pericytes; Promoter Regions, Genetic; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptor, Angiotensin, Type 1; Receptors, Immunologic; Retina; RNA, Messenger; Telmisartan; Up-Regulation

2005
Constrictor and dilator effects of angiotensin II on cerebral arterioles.
    Stroke, 2005, Volume: 36, Issue:12

    Topics: Angiotensin II; Animals; Arterioles; Benzimidazoles; Benzoates; Calcium Channel Blockers; Captopril; Cerebral Arteries; Dose-Response Relationship, Drug; Imidazoles; Male; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Telmisartan; Tetraethylammonium; Vasoconstriction; Vasodilation

2005
Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.
    Microvascular research, 2005, Volume: 70, Issue:3

    Topics: Administration, Oral; Age Factors; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Benzimidazoles; Benzoates; Blotting, Western; Coronary Artery Disease; Disease Progression; DNA Primers; Endothelial Cells; Endothelium, Vascular; Female; Humans; Hypertension; Male; Microcirculation; Middle Aged; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Telmisartan; Time Factors; Up-Regulation

2005
Novel polymer monolith microextraction using a poly(methacrylic acid-ethylene glycol dimethacrylate) monolith and its application to simultaneous analysis of several angiotensin II receptor antagonists in human urine by capillary zone electrophoresis.
    Journal of chromatography. A, 2006, Jan-13, Volume: 1102, Issue:1-2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Biphenyl Compounds; Electrophoresis, Capillary; Ethylene Glycols; Humans; Irbesartan; Losartan; Methacrylates; Receptors, Angiotensin; Sensitivity and Specificity; Telmisartan; Tetrazoles

2006
Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2005, Volume: 28, Issue:7

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Body Weight; Carotid Artery Diseases; Gene Expression; Hypertension; Immunohistochemistry; Lipids; Losartan; Male; Membrane Transport Proteins; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type III; Organ Size; Phosphoproteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Telmisartan; Vasodilation

2005
Angiotensin II type 1 receptor antagonist protects ventricular and coronary endothelial function after 24-hour heart preservation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:12

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Coronary Vessels; Creatine Kinase; Endothelium; Heart Transplantation; Hypothermia, Induced; Nitric Oxide; Rabbits; Receptor, Angiotensin, Type 1; Regional Blood Flow; Reperfusion Injury; Telmisartan; Vasodilation; Ventricular Function

2005
Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.
    Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:10

    Topics: Angiogenesis Inducing Agents; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Line; Cell Movement; Choroidal Neovascularization; Endothelial Cells; Humans; Inflammation; Inflammation Mediators; Macrophages; Mice; Mice, Inbred C57BL; PPAR gamma; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Telmisartan; Tissue Distribution

2006
Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Cardiovascular research, 2006, Oct-01, Volume: 72, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Aorta, Thoracic; Benzimidazoles; Benzoates; Blotting, Northern; Blotting, Western; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Promoter Regions, Genetic; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; RNA, Messenger; Telmisartan; Transcription, Genetic

2006
Telmisartan attenuates chronic ciclosporin A nephrotoxicity in a pig model.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Biopsy; Blood Flow Velocity; Blood Pressure; Cyclosporine; Disease Models, Animal; Female; Follow-Up Studies; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Magnetic Resonance Imaging; Renal Circulation; Swine; Telmisartan; Treatment Outcome

2007
C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice.
    Circulation, 2007, Feb-27, Volume: 115, Issue:8

    Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; C-Reactive Protein; Down-Regulation; Hypertension; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Systole; Telmisartan

2007
Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action.
    The Prostate, 2007, Jun-15, Volume: 67, Issue:9

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Cell Division; Cell Line, Tumor; Genes, Reporter; Humans; Male; Mitogen-Activated Protein Kinases; PPAR gamma; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Telmisartan

2007
Do all angiotensin II type 1 receptor blockers have the same beneficial effects?
    British journal of pharmacology, 2007, Volume: 151, Issue:7

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Humans; Imidazoles; Molecular Structure; Protein Binding; Receptor, Angiotensin, Type 1; Telmisartan; Tetrazoles

2007
Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor.
    British journal of pharmacology, 2007, Volume: 151, Issue:7

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Drug Synergism; Humans; Imidazoles; Inositol Phosphates; Molecular Structure; Protein Binding; Radioligand Assay; Receptor, Angiotensin, Type 1; Telmisartan; Tetrazoles; Time Factors; Tritium

2007
WB1106, a novel nitric oxide-releasing derivative of telmisartan, inhibits hypertension and improves glucose metabolism in rats.
    European journal of pharmacology, 2007, Dec-22, Volume: 577, Issue:1-3

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Benzimidazoles; Benzoates; Blood Pressure; Cyclic GMP; Diet; Dietary Carbohydrates; Dietary Fats; Glucose; Insulin Resistance; Male; Muscle Contraction; Muscle Relaxation; Nitric Oxide; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Telmisartan; Vasoconstriction; Vasoconstrictor Agents

2007
Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation.
    Human reproduction (Oxford, England), 2008, Volume: 23, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Line, Tumor; Cell Proliferation; Estradiol; Female; Leiomyoma; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Telmisartan; Uterine Neoplasms

2008
[Nephrotoxicity of high- and low-osmolar contrast media: Protective role of fosinopril or telmisartan in a rat model].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2007, Volume: 32, Issue:5

    Topics: Angiotensin II; Animals; Apoptosis; Benzimidazoles; Benzoates; Caspase 3; Claudin-1; Contrast Media; Creatinine; Female; Fosinopril; Kidney; Male; Protective Agents; Rats; Rats, Sprague-Dawley; Telmisartan

2007
Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 51, Issue:3

    Topics: Acrylates; Amidohydrolases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Anilides; Arginine; Benzimidazoles; Benzoates; Cells, Cultured; Cellular Senescence; Down-Regulation; Endothelium, Vascular; Humans; Imidazoles; Nitric Oxide; Oxidative Stress; PPAR gamma; Receptor, Angiotensin, Type 1; Signal Transduction; Telmisartan; Thiophenes; Up-Regulation

2008
Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2007, Volume: 30, Issue:12

    Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Carotid Arteries; Disease Models, Animal; Hypertension; Male; NADPH Oxidases; Peptidyl-Dipeptidase A; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Telmisartan; Tetrazoles; Valine; Valsartan; Vasodilation; Vasodilator Agents

2007
Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
    Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Benzimidazoles; Benzoates; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Fibrosis; Heart Rate; Hypertension; Hypertrophy; Kidney; Losartan; Male; Myocardium; Organ Specificity; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium, Dietary; Telmisartan

2008
[An experimental study of expression of angiotension converting enzyme 2 in myocardium and effect of telmisartan treatment in pressure-overloaded rats].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2008, Volume: 20, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aortic Coarctation; Benzimidazoles; Benzoates; Disease Models, Animal; Male; Myocardium; Peptidyl-Dipeptidase A; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Telmisartan

2008
Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina.
    Diabetes, 2008, Volume: 57, Issue:8

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Line; Diabetes Mellitus, Experimental; Extracellular Signal-Regulated MAP Kinases; Immunoblotting; Mice; Mice, Inbred C57BL; Neurons; Oncogene Protein v-akt; Phosphorylation; Receptor, Angiotensin, Type 1; Retina; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; STAT3 Transcription Factor; Synaptophysin; Telmisartan; Tetrazoles; Ubiquitination; Valine; Valsartan

2008
Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.
    Journal of hypertension, 2008, Volume: 26, Issue:9

    Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hypertension, Renal; Kidney Cortex; Male; Podocytes; Rats; Rats, Inbred OLETF; RNA, Messenger; Telmisartan

2008
Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor.
    Investigative ophthalmology & visual science, 2008, Volume: 49, Issue:10

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blotting, Western; Chemokine CCL2; Corneal Neovascularization; Corneal Stroma; Epithelium, Corneal; Gene Expression; Immunohistochemistry; Intercellular Adhesion Molecule-1; Interleukin-6; Macrophages; Male; Mice; Mice, Inbred C57BL; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Telmisartan; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2008
Angiotensin inhibition stimulates PPARgamma and the release of visfatin.
    European journal of clinical investigation, 2008, Volume: 38, Issue:11

    Topics: Adipocytes; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blotting, Western; Endothelial Cells; Humans; Intra-Abdominal Fat; Lisinopril; Muscle, Skeletal; Nicotinamide Phosphoribosyltransferase; PPAR gamma; Receptor, IGF Type 1; Rosiglitazone; Telmisartan; Tetrazoles; Thiazolidinediones; Umbilical Veins; Valine; Valsartan

2008
Increased transient receptor potential canonical type 3 channels in vasculature from hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 53, Issue:1

    Topics: Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Benzimidazoles; Benzoates; Blood Pressure; Calcium; Calcium Channel Blockers; Cells, Cultured; Gene Expression Regulation; Hypertension; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Telmisartan; TRPC Cation Channels; Vasoconstrictor Agents

2009
ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.
    Therapeutic advances in cardiovascular disease, 2008, Volume: 2, Issue:4

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Kidney Diseases; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan

2008
Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2009, Volume: 29, Issue:3

    Topics: Albumins; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood-Brain Barrier; Cells, Cultured; Endothelial Cells; Iodine Radioisotopes; Male; Mice; Mice, Inbred Strains; Microvessels; Permeability; Receptor, Angiotensin, Type 1; Telmisartan

2009
Telmisartan, an angiotensin II type 1 receptor antagonist, attenuates T-type Ca2+ channel expression in neonatal rat cardiomyocytes.
    European journal of pharmacology, 2009, May-01, Volume: 609, Issue:1-3

    Topics: Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Benzimidazoles; Benzoates; Calcium Channels, T-Type; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiology; Extracellular Signal-Regulated MAP Kinases; F-Box Proteins; Flavonoids; Gene Expression Regulation; Heart Rate; Imidazoles; JNK Mitogen-Activated Protein Kinases; Membrane Potentials; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Patch-Clamp Techniques; Pyridines; Rats; Rats, Wistar; RNA, Messenger; Telmisartan; Tetrazoles; Time Factors; Valine; Valsartan; Zebrafish Proteins

2009
Correlation of soluble gp130 serum concentrations with arterial blood pressure.
    Journal of hypertension, 2009, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Carotid Arteries; Case-Control Studies; Cell Culture Techniques; Cells, Cultured; Cytokine Receptor gp130; Endothelin-1; Female; Gene Expression; Heart Rate; Humans; Immunohistochemistry; Male; Middle Aged; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Species Specificity; Stroke; Telemetry; Telmisartan; Time Factors; Tunica Intima; Tunica Media; Vasoconstrictor Agents; Young Adult

2009
Chronic production of peroxynitrite in the vascular wall impairs vasorelaxation function in SHR/NDmcr-cp rats, an animal model of metabolic syndrome.
    Journal of pharmacological sciences, 2009, Volume: 109, Issue:4

    Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Vessels; Blotting, Western; Enzyme Activation; Immunoenzyme Techniques; Luminescence; Male; Metabolic Syndrome; NADPH Oxidases; Nitric Oxide Synthase Type III; Nitroprusside; Peroxynitrous Acid; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Telmisartan; Tyrosine; Vasoconstrictor Agents; Vasodilation

2009
Angiotensin II stimulates MCP-1 production in rat glomerular endothelial cells via NAD(P)H oxidase-dependent nuclear factor-kappa B signaling.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2009, Volume: 42, Issue:6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blotting, Western; Chemokine CCL2; Endothelial Cells; Enzyme Inhibitors; Inflammation; Kidney Glomerulus; NADPH Oxidases; NF-kappa B; Onium Compounds; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Telmisartan

2009
The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model.
    Acta radiologica (Stockholm, Sweden : 1987), 2009, Volume: 50, Issue:7

    Topics: Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Caspase 3; Contrast Media; Creatinine; Diatrizoate; In Situ Nick-End Labeling; Iohexol; Kidney Diseases; Osmolar Concentration; Random Allocation; Rats; Rats, Sprague-Dawley; Telmisartan

2009
HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation.
    American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:3

    Topics: Actins; AIDS-Associated Nephropathy; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cadherins; Calcium-Binding Proteins; Cell Proliferation; Cell Transdifferentiation; Disease Models, Animal; Epithelial Cells; Fibroblasts; HIV-1; Infusions, Subcutaneous; Kidney Glomerulus; Kidney Tubules; Macrophages; Mice; Mice, Transgenic; Phenotype; Podocytes; Proliferating Cell Nuclear Antigen; Receptor, Angiotensin, Type 1; RNA, Messenger; S100 Calcium-Binding Protein A4; S100 Proteins; T-Lymphocytes; Telmisartan

2010
Angiotensin II enhances interleukin-1 beta-induced MMP-9 secretion in adult rat cardiac fibroblasts.
    The Journal of veterinary medical science, 2010, Volume: 72, Issue:6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Heart; Humans; Interleukin-1beta; Male; Matrix Metalloproteinase 1; Myocardium; Phosphorylation; Rats; Rats, Wistar; Recombinant Proteins; Telmisartan

2010
Citrus limetta leaves extract antagonizes the hypertensive effect of angiotensin II.
    Journal of ethnopharmacology, 2010, Apr-21, Volume: 128, Issue:3

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Citrus; Clinical Trials as Topic; Dosage Forms; Humans; Hypertension; Male; Mexico; Mice; Mice, Inbred ICR; Plant Leaves; Random Allocation; Telmisartan

2010
A single-nucleotide polymorphism of alanine to threonine at position 163 of the human angiotensin II type 1 receptor impairs Losartan affinity.
    Pharmacogenetics and genomics, 2010, Volume: 20, Issue:6

    Topics: Alanine; Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Chlorocebus aethiops; COS Cells; Humans; Imidazoles; Inositol Phosphates; Irbesartan; Losartan; Polymorphism, Single Nucleotide; Receptor, Angiotensin, Type 1; Telmisartan; Tetrazoles; Threonine; Valine; Valsartan

2010
Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients.
    Heart and vessels, 2010, Volume: 25, Issue:3

    Topics: Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Cholesterol; Drug Administration Schedule; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Peptidyl-Dipeptidase A; Prospective Studies; Renin; Renin-Angiotensin System; Telmisartan; Time Factors; Treatment Outcome; Triglycerides

2010
Telmisartan regresses left ventricular hypertrophy in caveolin-1-deficient mice.
    Laboratory investigation; a journal of technical methods and pathology, 2010, Volume: 90, Issue:11

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Caveolin 1; Gene Expression Regulation; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 2; Telmisartan

2010
p63RhoGEF--a key mediator of angiotensin II-dependent signaling and processes in vascular smooth muscle cells.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2010, Volume: 24, Issue:12

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Calcium; Cells, Cultured; Endothelin-1; Fluorescent Antibody Technique; Guanine Nucleotide Exchange Factors; Imidazoles; Immunoblotting; Immunohistochemistry; Lysophospholipids; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pyridines; Rats; Rats, Wistar; Serotonin; Signal Transduction; Sphingosine; Telmisartan

2010
Impact of RGS2 deficiency on the therapeutic effect of telmisartan in angiotensin II-induced aortic aneurysm.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:12

    Topics: Alleles; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Aneurysm; Benzimidazoles; Benzoates; Blood Pressure; Genotype; Male; Mice; Mice, Knockout; Neovascularization, Physiologic; RGS Proteins; Superoxides; Telmisartan

2010
Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions.
    Toxicology, 2011, Jan-11, Volume: 279, Issue:1-3

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antioxidants; Benzimidazoles; Benzoates; Daunorubicin; Gene Expression Regulation; Kidney; Kidney Diseases; Kidney Function Tests; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Telmisartan

2011
[The role of renin-angiotensin system independent angiotensin II production in progression and fibrosis of intrahepatic cholangiocarcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Disease Progression; Fibrosis; Hepatic Stellate Cells; Humans; Receptor, Angiotensin, Type 1; Telmisartan

2010
Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
    Free radical research, 2011, Volume: 45, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Benzoates; Collagen Type III; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Hypertrophy; Intracellular Signaling Peptides and Proteins; Kidney; Mice; NADPH Oxidases; Oxidative Stress; Peptidyl-Dipeptidase A; PPAR gamma; Protein Serine-Threonine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Superoxides; Telmisartan; Transforming Growth Factor beta1; Up-Regulation

2011
Correlation of different NADPH oxidase homologues with late endothelial progenitor cell senescence induced by angiotensin II: effect of telmisartan.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:16

    Topics: Angiotensin II; Antihypertensive Agents; Benzimidazoles; Benzoates; Cells, Cultured; Cellular Senescence; Endothelial Cells; Humans; NADPH Oxidases; Stem Cells; Telmisartan; Up-Regulation

2011
Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.
    British journal of pharmacology, 2012, Volume: 165, Issue:8

    Topics: Adipose Tissue; Adrenocorticotropic Hormone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Corticosterone; Drug Therapy, Combination; Feeding Behavior; Heart Rate; Leptin; Male; Obesity; Ramipril; Rats; Rats, Inbred SHR; Telmisartan; Weight Gain

2012
Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARγ activation.
    Journal of cardiovascular pharmacology, 2012, Volume: 59, Issue:6

    Topics: Angiotensin II; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Benzimidazoles; Benzoates; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Down-Regulation; Humans; Macrophages; Monocytes; PPAR gamma; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Telmisartan; Tetrazoles; Valine; Valsartan

2012
Real-time monitoring of the effects of telmisartan on angiotensin II-induced mechanical changes in live mesangial cells using atomic force microscopy.
    Kidney & blood pressure research, 2012, Volume: 35, Issue:6

    Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; Computer Systems; Male; Mesangial Cells; Microscopy, Atomic Force; Rats; Rats, Sprague-Dawley; Telmisartan; Treatment Outcome

2012
Therapeutic role of telmisartan against acetaminophen hepatotoxicity in mice.
    European journal of pharmacology, 2012, Oct-15, Volume: 693, Issue:1-3

    Topics: Acetaminophen; Alanine Transaminase; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antioxidants; Benzimidazoles; Benzoates; Catalase; Chemical and Drug Induced Liver Injury; Glutathione; Liver; Male; Malondialdehyde; Mice; Nitric Oxide; Superoxide Dismutase; Telmisartan

2012
Telmisartan inhibits AGE-induced podocyte damage and detachment.
    Microvascular research, 2013, Volume: 88

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blotting, Western; Cell Adhesion; Diabetic Nephropathies; Disease Models, Animal; DNA Damage; Glycation End Products, Advanced; L-Lactate Dehydrogenase; Mice; Podocytes; Telmisartan

2013
Hypoxia-inducible factor-1α in vascular smooth muscle regulates blood pressure homeostasis through a peroxisome proliferator-activated receptor-γ-angiotensin II receptor type 1 axis.
    Hypertension (Dallas, Tex. : 1979), 2013, Volume: 62, Issue:3

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Hypoxia-Inducible Factor 1, alpha Subunit; Mesenteric Arteries; Mice; Mice, Knockout; Muscle, Smooth, Vascular; PPAR gamma; Receptor, Angiotensin, Type 1; Signal Transduction; Telmisartan

2013
Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:1

    Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blotting, Western; Collagen; Echocardiography; Fibrosis; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Telmisartan; Transforming Growth Factor beta1

2014
Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; Blood Pressure; Cell Proliferation; Cysts; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Hepatocytes; Humans; Kidney Function Tests; Liver; Liver Diseases; Liver Function Tests; Male; Organ Size; Polycystic Kidney, Autosomal Recessive; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Telmisartan; Transforming Growth Factor beta

2013
Hypoxia-induced collagen synthesis of human lung fibroblasts by activating the angiotensin system.
    International journal of molecular sciences, 2013, Dec-10, Volume: 14, Issue:12

    Topics: Angiotensin II; Angiotensinogen; Benzimidazoles; Benzoates; Cell Hypoxia; Cell Line; Collagen Type I; Fibroblasts; Gene Expression Regulation; Humans; Imidazoles; Lung; NF-kappa B; Peptidyl-Dipeptidase A; Pyridines; Pyrrolidines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Telmisartan; Thiocarbamates

2013
Telmisartan attenuates cognitive impairment caused by chronic stress in rats.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:3

    Topics: Angiotensin II; Animals; Anxiety; Benzimidazoles; Benzoates; Cognition Disorders; Male; Maze Learning; Memory; Mental Recall; Motor Activity; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Stress, Psychological; Telmisartan

2014
Improvement in spatial memory dysfunction by telmisartan through reduction of brain angiotensin II and oxidative stress in experimental uremic mice.
    Life sciences, 2014, Sep-15, Volume: 113, Issue:1-2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Brain; Cognition Disorders; DNA Damage; Lipid Peroxidation; Male; Maze Learning; Memory; Mice; Nephrectomy; Oxidative Stress; Reproducibility of Results; Spatial Behavior; Telmisartan; Uremia

2014
Synergistic effect of angiotensin II on vascular endothelial growth factor-A-mediated differentiation of bone marrow-derived mesenchymal stem cells into endothelial cells.
    Stem cell research & therapy, 2015, Jan-06, Volume: 6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antigens, CD; Benzimidazoles; Benzoates; Bone Marrow Cells; Cadherins; Cell Differentiation; Drug Synergism; Endothelial Cells; Femur; Imidazoles; Mesenchymal Stem Cells; Microscopy, Fluorescence; Pyridines; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA Interference; RNA, Small Interfering; Swine; Telmisartan; Vascular Endothelial Growth Factor A; von Willebrand Factor

2015
Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway.
    British journal of pharmacology, 2015, Volume: 172, Issue:15

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Benzimidazoles; Benzoates; Diet; Energy Intake; Energy Metabolism; Insulin Resistance; Leptin; Male; Obesity; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Signal Transduction; Telmisartan; Weight Gain; Weight Loss

2015
Differential role of angiotensin neuropeptides in repeated exposure of immobilization stress of varying duration in mice.
    Life sciences, 2015, Nov-15, Volume: 141

    Topics: Adaptation, Psychological; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Behavior, Animal; Benzimidazoles; Benzoates; Corticosterone; Hypothalamo-Hypophyseal System; Interpersonal Relations; Mice; Motor Activity; Neuropeptides; Restraint, Physical; Stress, Psychological; Telmisartan

2015
Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis.
    European journal of pharmacology, 2015, Oct-15, Volume: 765

    Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; Cardiotonic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrosis; Heart Diseases; Insulin Resistance; Male; Rats; Rats, Wistar; Telmisartan; Treatment Outcome; Umbelliferones; Vasoconstriction

2015
[Telmisartan reduces retina vessel endothelial cell apoptosis via upregulating retinal ACE2-Ang-(1-7)-Mas axis in spontaneous hypertensive rats].
    Zhonghua xin xue guan bing za zhi, 2015, Volume: 43, Issue:7

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Benzimidazoles; Benzoates; Blood Pressure; Endothelial Cells; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Retina; Systole; Telmisartan; Up-Regulation

2015
Telmisartan inhibited angiotensin II-induced collagen metabolic imbalance without directly targeting TGF-β 1/Smad signaling pathway in cardiac fibroblasts.
    Minerva cardioangiologica, 2015, Volume: 63, Issue:6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Benzimidazoles; Benzoates; Blotting, Western; Cells, Cultured; Collagen; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Fibrosis; Rats; Signal Transduction; Smad Proteins; Telmisartan; Transforming Growth Factor beta1

2015
Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:10

    Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; Cholesterol; Diet, High-Fat; Dyslipidemias; Extracellular Matrix; Hep G2 Cells; Humans; Intracellular Signaling Peptides and Proteins; Lipid Metabolism; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Receptor, Angiotensin, Type 1; Receptors, LDL; Renin-Angiotensin System; Signal Transduction; Sterol Regulatory Element Binding Protein 2; Telmisartan

2016
Glucagon increase after chronic AT
    Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Cell Line; Dose-Response Relationship, Drug; Glucagon; Hypoglycemic Agents; Islets of Langerhans; Leptin; Male; Mice, Inbred C57BL; Rats, Sprague-Dawley; Rats, Zucker; Receptor, Angiotensin, Type 1; Telmisartan; Tetrazoles; Time Factors; Up-Regulation

2017
Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
    Journal of hypertension, 2017, Volume: 35, Issue:7

    Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Down-Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Kidney; Male; Nephritis; NF-kappa B; Proteinuria; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Telmisartan; Transforming Growth Factor beta

2017
Telmisartan ameliorates vascular endothelial dysfunction in coronary slow flow phenomenon (CSFP).
    Cell biochemistry and function, 2018, Volume: 36, Issue:1

    Topics: Angiotensin II; Animals; Benzimidazoles; Benzoates; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Humans; Male; Middle Aged; No-Reflow Phenomenon; Rabbits; Structure-Activity Relationship; Telmisartan

2018
[Angiotensin II promotes the expression of TXNIP through angiotensin II type 1 receptor in islet β cells].
    Sheng li xue bao : [Acta physiologica Sinica], 2018, Apr-25, Volume: 70, Issue:2

    Topics: Angiotensin II; Animals; Apoptosis; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carrier Proteins; Cell Cycle Proteins; Cell Line; Insulin-Secreting Cells; Rats; Receptor, Angiotensin, Type 1; Telmisartan; Up-Regulation

2018
Observations of the Effects of Angiotensin II Receptor Blocker on Angiotensin II-Induced Morphological and Mechanical Changes in Renal Tubular Epithelial Cells Using Atomic Force Microscopy.
    BioMed research international, 2018, Volume: 2018

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Cadherins; Epithelial Cells; Epithelial-Mesenchymal Transition; Imidazoles; Kidney Tubules, Distal; Microscopy, Atomic Force; Pyridines; Rats; Telmisartan

2018
Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity.
    BMC cardiovascular disorders, 2018, 07-03, Volume: 18, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Chronic Disease; Disease Models, Animal; Endothelial Cells; Heart Diseases; Hypoxia; Male; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Telmisartan

2018
Telmisartan attenuates kidney apoptosis and autophagy-related protein expression levels in an intermittent hypoxia mouse model.
    Sleep & breathing = Schlaf & Atmung, 2019, Volume: 23, Issue:1

    Topics: Angiotensin II; Animals; Apoptosis; Autophagy-Related Proteins; Blood Urea Nitrogen; Body Weight; Creatinine; Disease Models, Animal; Hypoxia; In Situ Nick-End Labeling; Kidney; Male; Mice; Mice, Inbred C57BL; Telmisartan

2019
Telmisartan inhibits Ang II-induced MMP-9 expression in macrophages in stabilizing atheromatous plaque.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:22

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cell Line; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; Macrophages; Matrix Metalloproteinase 9; Plaque, Atherosclerotic; Telmisartan

2018
Central angiotensin II type 1 receptor as a therapeutic target against frequent urination.
    Neurourology and urodynamics, 2019, Volume: 38, Issue:8

    Topics: Amphibian Proteins; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Male; Peptide Hormones; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Telmisartan; Urination

2019
Nox2+ myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1.
    Cardiovascular research, 2021, 01-01, Volume: 117, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Disease Models, Animal; Endothelial Cells; Heart Failure; Leukocyte Rolling; Macrophages; Male; Mice, Inbred C57BL; Monocytes; Muramidase; Myeloid Cells; Myocardial Infarction; NADPH Oxidase 2; Oxidative Stress; Receptor, Angiotensin, Type 1; Signal Transduction; Telmisartan; Vasculitis

2021
Endogenous β-endorphin plays a pivotal role in angiotensin II-mediated central neurochemical changes and pressor response.
    Chemico-biological interactions, 2021, Jun-01, Volume: 342

    Topics: Angiotensin II; Animals; beta-Endorphin; Blood Pressure; Corticotropin-Releasing Hormone; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Male; Naloxone; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Rats; Telmisartan

2021
The relationship of telmisartan with sclerostin in the osteoporosis model induced by ovariectomy in rats.
    The Journal of pharmacy and pharmacology, 2021, Dec-07, Volume: 73, Issue:12

    Topics: Adaptor Proteins, Signal Transducing; Alkaline Phosphatase; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Disease Models, Animal; Estrogens; Female; Genetic Markers; Osteocalcin; Osteogenesis; Osteopontin; Osteoporosis; Ovariectomy; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Tartrate-Resistant Acid Phosphatase; Telmisartan

2021
Endothelial MicroRNA-483-3p Is Hypertension-Protective.
    Oxidative medicine and cellular longevity, 2022, Volume: 2022

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Endothelial Cells; Exosomes; Humans; Hypertension; MicroRNAs; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Telmisartan

2022
Angiotensin II inhibition increases diuresis during acute sympathetic activation in intact and denervated kidneys in rats with chronic myocardial infarction.
    Heart and vessels, 2022, Volume: 37, Issue:9

    Topics: Angiotensin II; Animals; Blood Pressure; Diuresis; Kidney; Myocardial Infarction; Rats; Rats, Inbred WKY; Sympathetic Nervous System; Telmisartan

2022
Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects.
    Scientific reports, 2022, 06-13, Volume: 12, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Mice; Nitric Oxide; Receptor, Angiotensin, Type 1; Telmisartan; Vascular Remodeling

2022
Effect of Angiotensin receptor blockade on Plasma Osmolality and Neurohumoral Responses to High Environmental Temperature in Rats Fed a High Salt Diet.
    Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria, 2021, Dec-31, Volume: 36, Issue:2

    Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diet; Hypertension; Male; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Sodium Chloride; Sodium Chloride, Dietary; Telmisartan; Temperature

2021
Effect of angiotensin II pathway inhibitors on post-surgical adhesion band formation: a potential repurposing of old drugs.
    Injury, 2022, Volume: 53, Issue:11

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Drug Repositioning; Enalapril; Eosine Yellowish-(YS); Fibrosis; Hematoxylin; Inflammation; Pharmaceutical Preparations; Rats; Rats, Wistar; Sulfhydryl Compounds; Superoxide Dismutase; Telmisartan; Tissue Adhesions

2022
Telmisartan inhibits microglia-induced neurotoxic A1 astrocyte conversion via PPARγ-mediated NF-κB/p65 degradation.
    International immunopharmacology, 2023, Volume: 123

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Astrocytes; Culture Media, Conditioned; Cytokines; Microglia; NF-kappa B; PPAR gamma; Telmisartan; Tumor Necrosis Factor-alpha

2023